Diagnosis and Prevalence of Cirrhotic Cardiomyopathy: A Systematic Review and Meta-analysis

Seyed Alireza Shahvaran1, Orsolya Menyhárt2, Lisa Csedrik3

  • 1Interdisciplinary Gastroenterology Working Group, Semmelweis University, Budapest, Hungary.

Insights

Cirrhotic cardiomyopathy (CCM) is prevalent in 61% of patients using standard echocardiograms, but only 45% when using tissue Doppler imaging (TDI). TDI offers a more accurate diagnosis of cardiac dysfunction in cirrhosis.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Medical Diagnostics

Background:

  • Cirrhotic cardiomyopathy (CCM) is a complex cardiac dysfunction affecting patients with liver cirrhosis.
  • Current diagnostic criteria rely on echocardiography, but the sensitivity and specificity vary.
  • Tissue Doppler imaging (TDI) shows promise for more accurate cardiac assessment in cirrhosis.

Purpose of the Study:

  • To estimate the pooled prevalence of CCM using conventional 2D echocardiography and TDI.
  • To compare the diagnostic accuracy of 2D echocardiography versus TDI for CCM.
  • To establish population-specific echocardiographic values for cirrhotic patients.

Main Methods:

  • Meta-analysis of 12 selected cohort studies.
  • Inclusion of studies using either conventional 2D echocardiography or TDI for CCM diagnosis.
  • Analysis of echocardiographic data from 615 cirrhotic patients.

Main Results:

  • The pooled prevalence of CCM was 61% using the 2005 criteria with conventional echocardiography.
  • Using TDI, the pooled prevalence of CCM decreased to 45%.
  • Mean echocardiographic values in cirrhotic patients included LVEF 63.52%, deceleration time 229.04 ms, IVRT 87.71 ms, and E/A ratio 1.04.

Conclusions:

  • Conventional 2D echocardiography may lead to overdiagnosis of CCM compared to TDI.
  • TDI demonstrates higher sensitivity and specificity for detecting cardiac dysfunction in cirrhotic patients.
  • Accurate diagnosis of CCM is crucial for patient management and prognosis.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
149
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
176
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
96
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
113
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
179